BNP Paribas Financial Markets
BLTE

BNP Paribas Financial Markets’s Belite Bio BLTE Stock Holding History

BNP Paribas Financial Markets’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.19M Buy
32,525
+30,077
+1,229% +$5.06M ﹤0.01% 1994
2025
Q4 		$392K Sell
2,448
-9,101
-79% -$1.08M ﹤0.01% 3701
2025
Q3 		$855K Buy
11,549
+8,258
+251% +$542K ﹤0.01% 3229
2025
Q2 		$190K Buy
+3,291
New +$201K ﹤0.01% 3785
2025
Q1 		– Sell
-2,450
Closed -$155K – 5404
2024
Q4 		$155K Buy
+2,450
New +$162K ﹤0.01% 3998

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets's BLTE Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Belite Bio (BLTE) stake by 1,229% in Q1 2026, buying an estimated $5.06M and bringing the position to 32,525 shares worth $5.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

BNP Paribas Financial Markets first reported a position in BLTE in Q4 2024 and has held it in 5 quarters since. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • BNP Paribas Financial Markets held 32,525 shares of Belite Bio worth $5.19M as of Q1 2026.
  • BNP Paribas Financial Markets bought 30,077 Belite Bio shares in Q1 2026, an estimated $5.06M.
  • Belite Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #1994 holding.
  • BNP Paribas Financial Markets first reported a position in Belite Bio in Q4 2024 and has held it in 5 quarters since.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.